SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-211242
Filing Date
2024-08-30
Accepted
2024-08-30 17:23:12
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d832481ds3.htm S-3 388368
2 EX-1.3 d832481dex13.htm EX-1.3 16312
3 EX-4.3 d832481dex43.htm EX-4.3 301647
4 EX-5.1 d832481dex51.htm EX-5.1 15086
5 EX-5.2 d832481dex52.htm EX-5.2 8293
6 EX-23.1 d832481dex231.htm EX-23.1 1720
7 EX-FILING FEES d832481dexfilingfees.htm EX-FILING FEES 63733
8 GRAPHIC g832481g0829081529219.jpg GRAPHIC 2725
9 GRAPHIC g832481g45k94.jpg GRAPHIC 46462
  Complete submission text file 0001193125-24-211242.txt   864200
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281891 | Film No.: 241271174
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)